The Latest Breaking News from BSX

Due to Boston Scientific's strong performance relative to its industry peers over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.

With the market signaling a hot deck, risk-tolerant speculators will want to keep close tabs on BSX stock over the next week.

Boston Scientific is expected to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit rise.

Boston Scientific has recently outpaced the broader healthcare sector, with analysts maintaining a highly bullish outlook on its future performance.

From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton, Dickinson and Company (BDX), and The Cooper Companies (COO), which could boost your portfolio. Keep reading….

Boston Scientific has notably outpaced the broader market over the past year. As a result, analysts are holding a highly optimistic outlook for its future prospects.

Boston Scientific will release its fourth-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Boston Scientific has outperformed the Dow recently, and analysts are strongly optimistic about the stock’s prospects.

Boston Scientific has significantly outperformed the broader market over the past year, and analysts maintain a very bullish view on its outlook.

Boston Scientific shows impressive growth in Q3 results, garnering bullish analyst support despite clinical trial setbacks.